- Home
- HCC vs XGN Comparison
HCC vs XGN Comparison
Compare HCC & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- XGN
- Stock Information
- Founded
- HCC 2015
- XGN 2002
- Country
- HCC United States
- XGN United States
- Employees
- HCC N/A
- XGN N/A
- Industry
- HCC Coal Mining
- XGN Medical Specialities
- Sector
- HCC Energy
- XGN Health Care
- Exchange
- HCC Nasdaq
- XGN Nasdaq
- Market Cap
- HCC 2.3B
- XGN 138.3M
- IPO Year
- HCC 2017
- XGN 2019
- Fundamental
- Price
- HCC $46.15
- XGN $7.00
- Analyst Decision
- HCC Strong Buy
- XGN Strong Buy
- Analyst Count
- HCC 5
- XGN 2
- Target Price
- HCC $70.25
- XGN $7.50
- AVG Volume (30 Days)
- HCC 954.3K
- XGN 237.8K
- Earning Date
- HCC 07-31-2025
- XGN 08-04-2025
- Dividend Yield
- HCC 0.69%
- XGN N/A
- EPS Growth
- HCC N/A
- XGN N/A
- EPS
- HCC 2.01
- XGN N/A
- Revenue
- HCC $1,319,451,000.00
- XGN $56,724,000.00
- Revenue This Year
- HCC N/A
- XGN $19.39
- Revenue Next Year
- HCC $33.59
- XGN $13.27
- P/E Ratio
- HCC $22.92
- XGN N/A
- Revenue Growth
- HCC N/A
- XGN 1.78
- 52 Week Low
- HCC $38.00
- XGN $1.71
- 52 Week High
- HCC $75.53
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- HCC 42.30
- XGN 52.23
- Support Level
- HCC $40.80
- XGN $6.62
- Resistance Level
- HCC $47.97
- XGN $7.35
- Average True Range (ATR)
- HCC 1.84
- XGN 0.48
- MACD
- HCC -0.48
- XGN -0.10
- Stochastic Oscillator
- HCC 31.13
- XGN 29.63
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.